Hemab Therapeutics Holdings, Inc.
COAG$25.35▼ 3.13% 24h
Hemab Therapeutics Holdings, Inc.COAG$25.35
+$8.09(+46.91%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$1.18B
P/E ratio
—
EPS (diluted)
$-23.98
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-22.69M
Net margin
—
Gross margin
—
Dividends & financials
Hemab Therapeutics Holdings, Inc. (COAG) reported revenue of — and net income of $-22.69M, or $-23.98 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.